NCT05842447View on ClinicalTrials.gov

Effect of Pomanox® on Skin Ageing (POMASKIN)

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

March 5, 2024

Study Completion Date

October 28, 2024

Conditions
Skin Ageing
Interventions
DIETARY_SUPPLEMENT

367 mg Pomanox group

Treatment with 367 mg Pomanox®P30 during 12 weeks

DIETARY_SUPPLEMENT

700 mg Pomanox group

Treatment with 700 mg Pomanox®P30 during 12 weeks

DIETARY_SUPPLEMENT

Control group

Treatment with maltodextrin during 12 weeks

Trial Locations (2)

43204

Anna Crescenti, Reus

Eurecat, Reus

All Listed Sponsors
collaborator

Euromed, S.A.

UNKNOWN

lead

Fundació Eurecat

OTHER

NCT05842447 - Effect of Pomanox® on Skin Ageing (POMASKIN) | Biotech Hunter | Biotech Hunter